| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Total Operating Expense | 194.34 | 189.06 | 189.22 | 123.16 |
| Other Net | 1.83 | 0.65 | 1.11 | 0.60 |
| Total Adjustmentsto Net Income | 0.00 | - | - | - |
| Diluted Weighted Average Shares | 1.75 | 1.71 | 1.71 | 1.20 |
| Depreciation/ Amortization | 4.94 | 4.83 | 3.23 | 3.71 |
| Operating Income | 12.84 | 11.53 | 9.39 | 8.07 |
| Net Income | 6.64 | 5.89 | 6.02 | 4.07 |
| Income Availableto Com Excl Extra Ord | 6.64 | 5.89 | 6.02 | 4.07 |
| Other Operating Expenses Total | 24.17 | 29.75 | 28.47 | 15.96 |
| Net Income Before Taxes | 9.23 | 7.80 | 8.11 | 5.60 |
| Minority Interest | 0.14 | 0.29 | - | - |
| Net Income After Taxes | 6.50 | 5.60 | 6.02 | 4.07 |
| Income Availableto Com Incl Extra Ord | 6.64 | 5.89 | 6.02 | 4.07 |
| Costof Revenue Total | 151.37 | 141.70 | 146.26 | 92.20 |
| Gross Profit | 55.80 | 58.89 | 52.35 | 39.03 |
| Interest Inc( Exp) Net- Non- Op Total | -5.44 | -4.39 | -2.90 | -3.07 |
| Diluted Net Income | 6.64 | 5.89 | 6.02 | 4.07 |
| Provisionfor Income Taxes | 2.74 | 2.19 | 2.09 | 1.53 |
| period Type | - | - | - | - |
| Net Income Before Extra Items | 6.64 | 5.89 | 6.02 | 4.07 |
| Total Revenue | 207.17 | 200.59 | 198.61 | 131.23 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Revenue | 207.17 | 200.59 | 198.61 | 131.23 |
| Selling/ General/ Admin Expenses Total | 13.86 | 12.79 | 11.26 | 11.29 |
| Diluted Normalized EPS | 3.79 | 3.44 | 3.29 | 3.39 |
| Diluted EPS Excluding Extra Ord Items | 3.79 | 3.44 | 3.51 | 3.39 |
| Gain( Loss)on Saleof Assets | - | 0.00 | 0.50 | 0.00 |
Crop Life Science Dividend Crop Life Science Bonus Crop Life Science News Crop Life Science AGM Crop Life Science Rights Crop Life Science Splits Crop Life Science Board Meetings Crop Life Science Key Metrics Crop Life Science Shareholdings Crop Life Science Balance Sheet Crop Life Science Cashflow Crop Life Science Q1 Results Crop Life Science Q2 Results Crop Life Science Q3 Results Crop Life Science Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.